Description
This product utilizes CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone I1C1R22-20). We employs the pGEM (T7-GFP-IL-4-EcoRI) vector components and the SynExpress system of the exons RNA Editing/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD22
Clone
I1C1R22-20
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
GFP
Promoter
T7
Effector Gene
IL-4
Insertion Sites
EcoRI
Gene Modification
RNA Editing
Modification Domain
Exons
Carrier Type
pGEM
Transformation Accuracy
0.94
Cell Culture
Microcarrier Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.